AP NEWS

The Global Biologic Therapeutics Market 2018-2022; Dominated by AbbVie, Johnson & Johnson, Merck, and Pfizer - ResearchAndMarkets.com

January 9, 2019

DUBLIN--(BUSINESS WIRE)--Jan 9, 2019--The “Global Biologic Therapeutics Market 2018-2022” report has been added to ResearchAndMarkets.com’s offering.

The biologic therapeutics market will register a CAGR of over 11% by 2022.

Increasing incidence of chronic diseases and immunological disorders to drive growth in the market

Biologics are ideal for the treatment of chronic disorders including cancer, autoimmune disorders, hormonal deficiencies, neurological disorders, and other critical conditions.

The incidence of these diseases is rising significantly in developed nations. The increase in aging population and the lifestyle of people in these countries is responsible for the rise in occurrence of cancer, immunological disorders, and other chronic ailments.

Increasing investment in development of biologics

Biotechnological products help manufacturers to earn huge revenues because of the therapeutic benefits they provide. Thus, many pharmaceutical companies are moving toward the development of biologics.

Reimbursement challenges of new biologics

The reimbursements available for biologics are very limited compared with that available for conventional therapeutics, despite the high costs. Manufacturers are providing biologics with mandatory companion diagnostics, which increases the overall cost of that biologic, making it difficult for insurers to provide reimbursements.

Key Players

AbbVie Johnson & Johnson Merck Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

PART 05: PIPELINE ANALYSIS

PART 06: MARKET SIZING

PART 07: FIVE FORCES ANALYSIS

PART 08: MARKET SEGMENTATION BY TYPE OF THERAPEUTIC AGENT

Segmentation by therapeutic agent Comparison by therapeutic agent Monoclonal antibodies - Market size and forecast 2017-2022 Others - Market size and forecast 2017-2022 Vaccines - Market size and forecast 2017-2022 Cell and tissue-based therapy - Market size and forecast 2017-2022 Gene therapy - Market size and forecast 2017-2022 Market opportunity by therapeutic agent

PART 09: MARKET SEGMENTATION BY APPLICATION

Oncology Autoimmune and inflammatory diseases Hematology Others

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

Geographical segmentation Regional comparison Americas - Market size and forecast 2017-2022 EMEA - Market size and forecast 2017-2022 APAC - Market size and forecast 2017-2022 Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

PART 16: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors AbbVie Johnson & Johnson Merck Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/fkjkh8/the_global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005474/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biopharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/09/2019 08:45 AM/DISC: 01/09/2019 08:45 AM

http://www.businesswire.com/news/home/20190109005474/en

AP RADIO
Update hourly